Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice
Anne‐Marie Andersson, Peter Johannes Holst
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
Eleni Panagioti, Paul Klenerman, Lian Ni Lee, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 103
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
Amaia Vergara Bermejo, Emeline Ragonnaud, Joana Daradoumis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4843-4843
Open Access | Times Cited: 27
Virus-Like-Vaccines against HIV
Anne‐Marie Andersson, Melanie Schwerdtfeger, Peter Johannes Holst
Vaccines (2018) Vol. 6, Iss. 1, pp. 10-10
Open Access | Times Cited: 25
Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice
Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, et al.
Oncotarget (2019) Vol. 10, Iss. 14, pp. 1458-1472
Open Access | Times Cited: 19
An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice
Joana Daradoumis, Emeline Ragonnaud, Isabella Skandorff, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 926-926
Open Access | Times Cited: 5
The potential of adenoviral vaccine vectors with altered antigen presentation capabilities
Lasse Neukirch, Cyrielle Fougeroux, Anne‐Marie Andersson, et al.
Expert Review of Vaccines (2019) Vol. 19, Iss. 1, pp. 25-41
Open Access | Times Cited: 13
DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses
Liu Wan, Yik Chun Wong, Samantha M. Y. Chen, et al.
Vaccine (2018) Vol. 36, Iss. 31, pp. 4621-4632
Closed Access | Times Cited: 10
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine
Iris Valdés, Alienys Izquierdo, Karem Cobas, et al.
Journal of General Virology (2019) Vol. 100, Iss. 6, pp. 975-984
Open Access | Times Cited: 7
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Melanie Schwerdtfeger, Anne‐Marie Andersson, Lasse Neukirch, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes
Clive M. Michelo, Andrew Fioré-Gartland, Jama Dalel, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 472-472
Open Access
Page 1

Scroll to top